• Matthew J Singleton, Rohesh J Fernando, Prashant Bhave, Jerry R Clark, James E Johnson, S Patrick Whalen, and Roger L Royster.
• Section of Cardiology, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC.
• J. Cardiothorac. Vasc. Anesth. 2022 Jan 1; 36 (1): 236-241.

AbstractPerioperative management of implantable cardioverter-defibrillators is an important part of anesthetic care. Society recommendations and expert consensus statements exist to aid clinicians, and they have identified the umbilicus as an important landmark in decision-making. Implantable cardioverter-defibrillator antitachycardia therapy may not need to be deactivated for infraumbilical surgery because electromagnetic interference is unlikely to occur. The authors present two cases in which inappropriate antitachycardia therapy occurred intraoperatively with use of an underbody dispersive electrode, even though both surgeries were infraumbilical. The authors also present two cadaver models to demonstrate how monopolar electrosurgery below the umbilicus is sensed using both traditional and underbody dispersive electrosurgical return electrodes.Copyright © 2021 Elsevier Inc. All rights reserved.

12 keywords...

hide…